High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease
Open Access
- 1 January 2008
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 10 (3) , 209
- https://doi.org/10.1186/ar2440
Abstract
High-mobility group box protein 1 (HMGB1) is a non-histone nuclear protein that has a dual function. Inside the cell, HMGB1 binds DNA, regulating transcription and determining chromosomal architecture. Outside the cell, HMGB1 can serve as an alarmin to activate the innate system and mediate a wide range of physiological and pathological responses. To function as an alarmin, HMGB1 translocates from the nucleus of the cell to the extra-cellular milieu, a process that can take place with cell activation as well as cell death. HMGB1 can interact with receptors that include RAGE (receptor for advanced glycation endproducts) as well as Toll-like receptor-2 (TLR-2) and TLR-4 and function in a synergistic fashion with other proinflammatory mediators to induce responses. As shown in studies on patients as well as animal models, HMGB1 can play an important role in the pathogenesis of rheumatic disease, including rheumatoid arthritis, systemic lupus erythematosus, and polymyositis among others. New approaches to therapy for these diseases may involve strategies to inhibit HMGB1 release from cells, its interaction with receptors, and downstream signaling.This publication has 76 references indexed in Scilit:
- Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients – a prospective clinical studyArthritis Research & Therapy, 2008
- Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritisArthritis Research & Therapy, 2008
- Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infectionCritical Care, 2007
- The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammationBritish Journal of Pharmacology, 2007
- Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGENature Immunology, 2007
- Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritisArthritis Research & Therapy, 2007
- Physiology and immunology of the cholinergic antiinflammatory pathwayJournal of Clinical Investigation, 2007
- A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrinThe EMBO Journal, 2007
- Alarmin(g) news about dangerEMBO Reports, 2006
- Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vesselsArthritis & Rheumatism, 2005